The plasma 5′-AMP acts as a potential upstream regulator of hyperglycemia in type 2 diabetic mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 302, Issue 3, 2012, Pages 325-333

  Zhang, Ying ^a   Wang, Zhongqiu ^b   Zhao, Yue ^a   Zhao, Ming ^b   Wang, Shiming ^a   Hua, Zichun ^b   Zhang, Jianfa ^a  

^a NANJING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Adenosine 5 monophosphate; Free fatty acids; Glucose transporter 4; Glucose 6 phosphatase; Hyperglycemia

Indexed keywords

ADENOSINE PHOSPHATE; ADENOSINE RECEPTOR; FATTY ACID; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE TRANSPORTER 4; INSULIN; TRANSCRIPTION FACTOR FKHR; ADENOSINE; ISOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; HYPERGLYCEMIA; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKELETAL MUSCLE; WILD TYPE; ANIMAL; BLOOD; C57BL MOUSE; CELL CULTURE; CHEMISTRY; ENZYMOLOGY; FEMALE; GENETICS; GLYCOGENOLYSIS; HUMAN; INSULIN RESISTANCE; LIVER; METABOLISM; MOUSE MUTANT; NECROSIS; PATHOLOGY; PATHOPHYSIOLOGY; UMBILICAL VEIN ENDOTHELIAL CELL;

ADENOSINE; ADENOSINE MONOPHOSPHATE; ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, NONESTERIFIED; FEMALE; GLYCOGENOLYSIS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MUSCLE, SKELETAL; NECROSIS; PROTEIN ISOFORMS; RECEPTORS, PURINERGIC P1;

EID: 84856196038     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00424.2011     Document Type: Article

References (60)

1. Aasum E, Belke DD, Severson DL, Riemersma RA, Cooper M, Andreassen M, Larsen TS. Cardiac function and metabolism in Type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR-α activator. Am J Physiol Heart Circ Physiol 283: H949-H957, 2002.
2. Altomonte J, Richter A, Harbaran S, Suriawinata J, Nakae J, Thung SN, Meseck M, Accili D, Dong H. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. Am J Physiol Endocrinol Metab 285: E718-E728, 2003.
3. Aoki K, Kikuchi T, Mukasa K, Ito S, Nakajima A, Satoh S, Okamura A, Sekihara H. Dehydroepiandrosterone suppresses elevated hepatic glucose-6-phosphatase mRNA level in C57BL/KsJ-db/db mice: comparison with troglitazone. Endocr J 47: 799-804, 2000.
4. Bates SH, Kulkarni RN, Seifert M, Myers MG Jr. Roles for leptin receptor/STAT3-dependent and -independent signals in the regulation of glucose homeostasis. Cell Metab 1: 169-178, 2005.
5. Blackburn MR, Aldrich M, Volmer JB, Chen W, Zhong H, Kelly S, Hershfield MS, Datta SK, Kellems RE. The use of enzyme therapy to regulate the metabolic and phenotypic consequences of adenosine deaminase deficiency in mice. Differential impact on pulmonary and immunologic abnormalities. J Biol Chem 275: 32114-32121, 2000.
6. Boden G. Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver. Curr Diab Rep 6: 177-181, 2006.
7. Boden G. Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes 18: 139-143, 2011.
8. Cefalu WT. Animal models of type 2 diabetes: clinical presentation and pathophysiological relevance to the human condition. ILAR J 47: 186-198, 2006.
9. Chavez JA, Roach WG, Keller SR, Lane WS, Lienhard GE. Inhibition of GLUT4 translocation by Tbc1d1, a Rab GTPase-activating protein abundant in skeletal muscle, is partially relieved by AMP-activated protein kinase activation. J Biol Chem 283: 9187-9195, 2008.
10. Cushman S, Wardzala L. Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane. J Biol Chem 255: 4758-4762, 1980.
11. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI. Effects of free fatty acids on glucose transport and IRS-1- associated phosphatidylinositol 3-kinase activity. J Clin Invest 103: 253-259, 1999.
12. Facchini F, Chen YD, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 266: 3008-3011, 1991.
13. Ferreira AC, Peter AA, Mendez AJ, Jimenez JJ, Mauro LM, Chirinos JA, Ghany R, Virani S, Garcia S, Horstman LL, Purow J, Jy W, Ahn YS, de Marchena E. Postprandial hypertriglyceridemia increases circulating levels of endothelial cell microparticles. Circulation 10: 3599-3603, 2004.
14. Friedman JE, Sun Y, Ishizuka T, Farrell CJ, McCormack SE, Herron LM, Hakimi P, Lechner P, Yun JS. Phosphoenolpyruvate carboxykinase (GTP) gene transcription and hyperglycemia are regulated by glucocorticoids in genetically obese db/db transgenic mice. J Biol Chem 272: 31475-31481, 1997.
15. Garvey WT, Maianu L, Zhu JH, Brechtel-Hook G, Wallace P, Baron AD. Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest 101: 2377-2386, 1998.
16. Gibbs EM, Stock JL, McCoid SC, Stukenbrok HA, Pessin JE, Stevenson RW, Milici AJ, McNeish JD. Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). J Clin Invest 95: 1512-1518, 1995.
17. Halseth AE, Ensor NJ, White TA, Ross SA, Gulve EA. Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations. Biochem Biophys Res Commun 294: 798-805, 2002.
18. Han DC, Isono M, Chen S, Casaretto A, Hong SW, Wolf G, Ziyadeh FN. Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGF-beta type II receptor expression. Kidney Int 59: 1315-1323, 2001.
19. Hennig B, Toborek M, McClain CJ. High-energy diets, fatty acids and endothelial cell function: implications for atherosclerosis. J Am Coll Nutr 20: 97-105, 2001.
20. Herman MA, Kahn BB. Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. J Clin Invest 116: 1767-1775, 2006.
21. Houseknecht KL, Portocarrero CP. Leptin and its receptors: regulators of whole-body energy homeostasis. Domest Anim Endocrinol 15: 457-475, 1998.
22. Hummel KP, Dickie MM, Coleman DL. Diabetes, a new mutation in the mouse. Science 153: 1127-1128, 1966.
23. James D, Piper R, Slot J. Targeting of mammalian glucose transporters. J Cell Sci 104: 607-612, 1993.
24. Kahn A. Transcriptional regulation by glucose in the liver. Biochimie 79: 113-118, 1997.
25. Kaiser N, Nesher R, Donath MY, Fraenkel M, Behar V, Magnan C, Ktorza A, Cerasi E, Leibowitz G. Psammomys obesus, a model for environment-gene interactions in type 2 diabetes. Diabetes 54: S137-S144, 2005.
26. Klip A, Ramlal T, Bilan PJ, Cartee GD, Gulve EA, Holloszy JO. Recruitment of GLUT-4 glucose transporters by insulin in diabetic rat skeletal muscle. Biochem Biophys Res Commun 172: 728-736, 1990.
27. Knudsen TB, Winters RS, Otey SK, Blackburn MR, Airhart MJ, Church JK, Skalko RG. Effects of (R)-deoxycoformycin (pentostatin) on intrauterine nucleoside catabolism and embryo viability in the pregnant mouse. Teratology 45: 91-103, 1992.
28. Long YC, Zierath JR. AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest 116: 1776-1783, 2006.
29. Minassian C, Daniele N, Bordet JC, Zitoun C, Mithieux G. Liver glucose-6 phosphatase activity is inhibited by refeeding in rats. J Nutr 125: 2727-2732, 1995.
30. Miura T, Suzuki W, Ishihara E, Arai I, Ishida H, Seino Y, Tanigawa K. Impairment of insulin-stimulated GLUT4 translocation in skeletal muscle and adipose tissue in the Tsumura Suzuki obese diabetic mouse: a new genetic animal model of type 2 diabetes. Eur J Endocrinol 145: 785-790, 2001.
31. Musi N. AMP-activated protein kinase and type 2 diabetes. Curr Med Chem 13: 583-589, 2006.
32. Ogryzlo MA. Hyperuricemia induced by high fat diets and starvation. Arthritis Rheum 8: 799-822, 1965.
33. Osborn O, Sanchez-Alavez M, Brownell SE, Ross B, Klaus J, Dubins J, Beutler B, Conti B, Bartfai T. Metabolic characterization of a mouse deficient in all known leptin receptor isoforms. Cell Mol Neurobiol 30: 23-33, 2010.
34. Payne-Robinson HM, Brown R. The effect of malnutrition on insulin binding to rat erythrocytes. Br J Nutr 67: 279-286, 1992.
35. Perry IJ, Wannamethee SG, Walker MK, Thomson AG, Whincup PH, Shaper AG. Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. BMJ 310: 560-564, 1995.
36. Rees DA, Alcolado JC. Animal models of diabetes mellitus. Diabet Med 22: 359-370, 2005.
37. Rich SS. Mapping genes in diabetes. Genetic epidemiological perspective. Diabetes 39: 1315-1319, 1990.
38. Rosholt MN, King PA, Horton ES. High-fat diet reduces glucose transporter responses to both insulin and exercise. Am J Physiol Regul Integr Comp Physiol 266: R95-R101, 1994.
39. Rouser G, Fkeischer S, Yamamoto A. Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5: 494-496, 1970.
40. Ryder JW, Yang J, Galuska D, Rincón J, Björnholm M, Krook A, Lund S, Pedersen O, Wallberg-Henriksson H, Zierath JR, Holman GD. Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes 49: 647-654, 2000.
41. Sabirov RZ, Okada Y. ATP release via anion channels. Purinergic Signal 1: 311-328, 2005.
42. Schimmack G, Defronzo RA, Musi N. AMP-activated protein kinase: Role in metabolism and therapeutic implications. Diabetes Obes Metab 8: 591-602, 2006.
43. Seoane J, Trinh K, O'Doherty RM, Gómez-Foix AM, Lange AJ, Newgard CB, Guinovart JJ. Metabolic impact of adenovirus-mediated overexpression of the glucose-6-phosphatase catalytic subunit in hepatocytes. J Biol Chem 272: 26972-26977, 1997.
44. Sivan E, Boden G. Free fatty acids, insulin resistance, and pregnancy. Curr Diab Rep 3: 319-322, 2003.
45. Srinivasan K, Ramarao P. Animal models in type 2 diabetes research: an overview. Indian J Med Res 125: 451-472, 2007.
46. Staehr P, Hother-Nielsen O, Levin K, Holst JJ, Beck-Nielsen H. Assessment of hepatic insulin action in obese type 2 diabetic patients. Diabetes 50: 1363-1370, 2001.
47. Streeper RS, Svitek CA, Chapman S, Greenbaum LE, Taub R, O'Brien RM. A multicomponent insulin response sequence mediates a strong repression of mouse glucose-6-phosphatase gene transcription by insulin. J Biol Chem 272: 11698-11701, 1997.
48. Stumvoll M, Meyer C, Perriello G, Kreider M, Welle S, Gerich J. Human kidney and liver gluconeogenesis: evidence for organ substrate selectivity. Am J Physiol Endocrinol Metab 274: E817-E826, 1998.
49. Sun MS, Pan CJ, Shieh JJ, Ghosh A, Chen LY, Mansfield BC, Ward JM, Byrne BJ, Chou JY. Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type Ia in mice. Hum Mol Genet 11: 2155-2164, 2002.
50. Suzuki K, Kono T. Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site. Proc Natl Acad Sci USA 77: 2542-2545, 1980.
51. Towle HC, Kaytor EN, Shih HM. Regulation of the expression of lipogenic enzyme genes by carbohydrate. Annu Rev Nutr 17: 405-433, 1997.
52. Trinh KY, O'Doherty RM, Anderson P, Lange AJ, Newgard CB. Perturbation of fuel homeostasis caused by overexpression of the glucose- 6-phosphatase catalytic subunit in liver of normal rats. J Biol Chem 273: 31615-31620, 1998.
53. Tsao TS, Burcelin R, Katz EB, Huang L, Charron MJ. Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle. Diabetes 45: 28-36, 1996.
54. Unger RH, Clark GO, Scherer PE, Orci L. Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim Biophys Acta 1801: 209-214, 2010.
55. Wilding JP. The importance of free fatty acids in the development of Type 2 diabetes. Diabet Med 24: 934-945, 2007.
56. Wyne KL. Free fatty acids and type 2 diabetes mellitus. Am J Med 115: 29S-36S, 2003.
57. Xiao B, Heath R, Saiu P, Leiper FC, Leone P, Jing C, Walker PA, Haire L, Eccleston JF, Davis CT, Martin SR, Carling D, Gamblin SJ. Structural basis for AMP binding to mammalian AMP-activated protein kinase. Nature 449: 496-500, 2007.
58. Zhu P, Chen G, You T, Yao J, Jiang Q, Lin X, Shen X, Qiao Y, Lin L. High FFA-induced proliferation and apoptosis in human umbilical vein endothelial cell partly through Wnt/beta-catenin signal pathway. Mol Cell Biochem 338: 123-131, 2010.
59. Zierath JR, He L, Gumà A, Odegoard Wahlström E, Klip A, Wallberg- Henriksson H. Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia 39: 1180-1189, 1996.
60. Zierath JR, Houseknecht KL, Gnudi L, Kahn BB. High-fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin-signaling defect. Diabetes 46: 215-223, 1997.